You are here

Otezla

AbbVie's Skyrizi delivers head-to-head win versus Amgen's Otezla in psoriasis

Fierce Pharma

Wed, 07/26/23 - 11:37 am

Boehringer Ingelheim

Amgen nabs appeals win against Otezla generics, blocking Sandoz and Zydus copycats until 2028

Fierce Pharma

Thu, 04/20/23 - 11:47 am

Bristol Myers on track for 3rd new drug launch of 2022 with latest deucravacitinib data

Fierce Biotech

Thu, 05/12/22 - 10:48 am

Bristol Myers Squibb

deucravacitinib

clinical trials

Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs among large drugmakers

Fierce Pharma

Fri, 12/31/21 - 11:10 am

Bristol Myers Squibb

Amgen builds Otezla’s psoriasis label as rival BMS looms large

Pharmaforum

Wed, 12/22/21 - 11:19 am

Bristol Myers Squibb

deucravacitinib

Amgen's Otezla notches win in genital psoriasis, snagging possible edge against forthcoming BMS rival

Fierce Pharma

Thu, 12/2/21 - 12:25 pm

Bristol Myers Squibb

Amgen's Otezla, Repatha and biosimilars put on notice, with challenging years ahead

Fierce Pharma

Mon, 11/22/21 - 10:13 pm

Amgen scores Otezla patent win, protecting its blockbuster from Sandoz and Zydus generics until 2028

Fierce Pharma

Tue, 09/21/21 - 10:54 am

market exclusivity

Otezla maker Amgen challenges patient groups to help fix long-lasting psoriasis treatment gaps

Fierce Pharma

Fri, 07/23/21 - 11:05 am

Bristol Myers' next-gen immunology med busts Amgen's Otezla in head-to-head study. Is a showdown coming?

Endpoints

Fri, 04/23/21 - 11:12 am

Bristol Myers Squibb

deucravacitinib

Amgen Submits Supplemental NDA for Mild-to-Moderate Psoriasis Drug Otezla

BioSpace

Mon, 02/22/21 - 11:49 pm

Bristol Myers' psoriasis drug beats Amgen rival in phase 3

Fierce Biotech

Tue, 11/3/20 - 10:49 am

Bristol-Myers Squibb

deucravacitinib

plaque psoriasis

Thank Otezla for Amgen's Q3 Revenue and Earnings Beats

Motley Fool

Thu, 10/29/20 - 12:01 pm

Phase 3 wins put Dermavant closer to filing Otezla rival tapinarof

Pharmaforum

Thu, 08/27/20 - 11:04 am

clinical trials

AbbVie's Skyrizi stands to gain as docs move away from older psoriasis meds—Amgen's Otezla included

Fierce Pharma

Tue, 08/25/20 - 11:12 am

Amgen ramps up Otezla expansion effort with positive data in mild psoriasis

Fierce Pharma

Thu, 05/7/20 - 12:27 am

Amgen to test psoriasis pill Otezla in COVID-19

Pharmaforum

Sun, 05/3/20 - 07:54 pm

clinical trials

Amgen's anti-inflammatory Otezla makes its foray into COVID-19

Fierce Pharma

Fri, 05/1/20 - 12:47 pm

Amgen juices up sales outlook amid high hopes for Celgene castoff Otezla

Fierce Pharma

Thu, 11/21/19 - 06:29 pm

[podcast+transcript]Why Amgen's Spending Billions to Buy This 1 Drug

Motley Fool

Sat, 09/7/19 - 06:16 pm

Bristol-Myers Squibb

Pages